Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: A placebo-controlled multicenter trial: Discussion

Ophthalmology

Volumn 110, Issue 10, 2003, Pages 1919-

  Liesegang, Thomas J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

CLINICAL TRIAL; CORNEA TRANSPLANTATION; GRAFT FAILURE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HUMAN; NOTE; POLYMERASE CHAIN REACTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT INFECTION; VIRUS SHEDDING;

EID: 0348044622     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00797-8     Document Type: Note

References (9)

1. Remeijer L, Doornenbal P, Geerards AJ, et al. Newly acquired herpes simplex virus keratitis after penetrating keratoplasty. Ophthalmology 1997;104:648-52.
2. Kaufman HE, Brown DC, Ellison EM. Recurrent herpes in the rabbit and man. Science 1967;156:1628-9.
3. Kaye SB, Madan N, Dowd TC, et al. Ocular shedding of herpes simplex virus. Br J Ophthalmol 1990;74:114-6.
4. Cleator GM, Klapper PE, Dennett C, et al. Corneal donor infection by herpes simplex virus: herpes simplex virus DNA in donor corneas. Cornea 1994;13:294-304.
5. Cockerham GC, Krafft AE, McLean IW. Herpes simplex virus in primary graft failure. Arch Ophthalmol 1997; 115:586-9.
6. Holbach LM, Asano N, Naumann GO. Infection of the corneal endothelium in herpes simplex keratitis. Am J Ophthalmol 1998;126:592-4.
7. Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998;339:300-6.
8. Jabs DA. Acyclovir for recurrent herpes simplex ocular disease. N Engl J Med 1998;339:340-1.
9. Moyes AL, Sugar A, Musch DC, Barnes RD. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 1994;112:601-7.